RCAG
AMED

Rehmann Capital Advisory Group’s Amedisys AMED Stock Holding History

Rehmann Capital Advisory Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$33.9K Hold
259
– – ﹤0.01% 742
2019
Q2 		$31.4K Buy
+259
New +$30.7K ﹤0.01% 1001

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Rehmann Capital Advisory Group's AMED Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Amedisys (AMED) position steady in Q3 2019 at 259 shares worth $33.9K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

Rehmann Capital Advisory Group first reported a position in AMED in Q2 2019 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

  • Rehmann Capital Advisory Group held 259 shares of Amedisys worth $33.9K as of Q3 2019.
  • Rehmann Capital Advisory Group left its Amedisys share count unchanged in Q3 2019.
  • Amedisys made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #742 holding.
  • Rehmann Capital Advisory Group first reported a position in Amedisys in Q2 2019 and has held it in 2 quarters since.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.